Mary K Gospodarowicz

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. pmc Image guided dose escalated prostate radiotherapy: still room to improve
    Jarad M Martin
    Princess Margaret Hospital, Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Radiat Oncol 4:50. 2009
  2. ncbi request reprint Patient management scenario: a framework for clinical decision and prognosis
    Mary Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, University Health Network, ON, Canada
    Semin Surg Oncol 21:8-12. 2003
  3. doi request reprint Hodgkin's lymphoma--patient's assessment and staging
    Mary K Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
    Cancer J 15:138-42. 2009
  4. ncbi request reprint Prognostic factors in cancer
    Mary Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, University Health Network, ON, Canada
    Semin Surg Oncol 21:13-8. 2003
  5. doi request reprint Testicular cancer patients: considerations in long-term follow-up
    Mary Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    Hematol Oncol Clin North Am 22:245-55, vi. 2008
  6. pmc ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
    Ralph M Meyer
    Cancer Research Institute, Queen s University, Kingston, ON, Canada
    N Engl J Med 366:399-408. 2012
  7. ncbi request reprint Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma
    Eng Siew Koh
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 66:223-8. 2006
  8. ncbi request reprint Stage II testicular seminoma: patterns of recurrence and outcome of treatment
    Peter W M Chung
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    Eur Urol 45:754-59; discussion 759-60. 2004
  9. doi request reprint Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant
    Jayant S Goda
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 84:e329-35. 2012
  10. ncbi request reprint Low-grade non-hodgkin lymphomas
    Richard W Tsang
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
    Semin Radiat Oncol 17:198-205. 2007

Detail Information

Publications60

  1. pmc Image guided dose escalated prostate radiotherapy: still room to improve
    Jarad M Martin
    Princess Margaret Hospital, Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Radiat Oncol 4:50. 2009
    ..The primary objective was to assess 5-year biochemical control and potential prognostic factors by the Phoenix definition. Secondary endpoints included acute and late toxicity by the Radiotherapy Oncology Group (RTOG) scoring scales...
  2. ncbi request reprint Patient management scenario: a framework for clinical decision and prognosis
    Mary Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, University Health Network, ON, Canada
    Semin Surg Oncol 21:8-12. 2003
    ..A deliberate and careful determination of prognosis is essential to clinical decision making and patient care. We illustrate the use of the concept of management scenario in several clinical examples...
  3. doi request reprint Hodgkin's lymphoma--patient's assessment and staging
    Mary K Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
    Cancer J 15:138-42. 2009
    ....
  4. ncbi request reprint Prognostic factors in cancer
    Mary Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, University Health Network, ON, Canada
    Semin Surg Oncol 21:13-8. 2003
    ..The acceptance of a generic prognostic factor classification would facilitate communication and education about this most important subject in oncology...
  5. doi request reprint Testicular cancer patients: considerations in long-term follow-up
    Mary Gospodarowicz
    Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    Hematol Oncol Clin North Am 22:245-55, vi. 2008
    ..An overview of these late effects and recommendations for patient follow-up are presented in this article...
  6. pmc ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
    Ralph M Meyer
    Cancer Research Institute, Queen s University, Kingston, ON, Canada
    N Engl J Med 366:399-408. 2012
    ..Chemotherapy alone may improve survival because it is associated with fewer late deaths...
  7. ncbi request reprint Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma
    Eng Siew Koh
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 66:223-8. 2006
    ..To quantify the incidence of radiation pneumonitis (RP) in a modern Hodgkin's lymphoma (HL) cohort, and to identify any clinically relevant parameters that may influence the risk of RP...
  8. ncbi request reprint Stage II testicular seminoma: patterns of recurrence and outcome of treatment
    Peter W M Chung
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    Eur Urol 45:754-59; discussion 759-60. 2004
    ..To review treatment outcome and patterns of failure for patients with stage II testicular seminoma and to identify prognostic factors for relapse...
  9. doi request reprint Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant
    Jayant S Goda
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 84:e329-35. 2012
    ..To analyze, through chart review, the efficacy of salvage radiation therapy (sRT) for relapsed or progressive Hodgkin lymphoma (HL) patients who failed autologous stem cell transplant (ASCT)...
  10. ncbi request reprint Low-grade non-hodgkin lymphomas
    Richard W Tsang
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
    Semin Radiat Oncol 17:198-205. 2007
    ..Patients with stage III and IV low-grade lymphoma and local symptoms are often successfully palliated with a low dose regimen of 2 x 2 Gy (total dose 4 Gy)...
  11. ncbi request reprint Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy
    David C Hodgson
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada
    Hematol Oncol 25:11-5. 2007
    ..Female HL patients who had survived without recurrence > or =3 years and who had attempted pregnancy after ABVD did not experience significant sub-fertility...
  12. ncbi request reprint Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma
    Chandra Martens
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 64:1183-7. 2006
    ..Local symptoms are treated with radiotherapy (RT) for local control. We have reviewed local control and toxicity in patients treated with hyperfractionated accelerated RT...
  13. ncbi request reprint Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy
    David C Hodgson
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 57:1374-81. 2003
    ..To examine the impact of extranodal chest wall and lung invasion on the prognosis of patients with clinical Stage I-II Hodgkin's lymphoma treated with combined modality therapy...
  14. ncbi request reprint Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
    Ralph M Meyer
    Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada
    J Clin Oncol 23:4634-42. 2005
    ..We report results of a randomized trial comparing ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy alone with treatment that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma...
  15. doi request reprint No role for routine chest radiography in stage I seminoma surveillance
    Shaun Tolan
    Department of Radiation Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada
    Eur Urol 57:474-9. 2010
    ..The optimal follow-up protocol for surveillance is yet to be determined but includes frequent chest radiography (CXR) and computed tomography (CT) scan of the abdomen and pelvis (CT-AP)...
  16. ncbi request reprint Long-term outcome of radiation-based conservation therapy for invasive bladder cancer
    Peter W M Chung
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network and University of Toronto, Toronto, Ontario M5G 2M9, Canada
    Urol Oncol 25:303-9. 2007
    ..To report the long-term results and examine factors associated with bladder preservation, risk of relapse, and survival in patients treated with radical radiotherapy for invasive bladder cancer...
  17. ncbi request reprint Radiation therapy for localized low-grade non-Hodgkin's lymphomas
    Richard W Tsang
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Ontario, Canada
    Hematol Oncol 23:10-7. 2005
    ....
  18. doi request reprint Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity
    Jayant Sastri Goda
    Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 81:e659-66. 2011
    ..To evaluate the clinical outcomes and late effects of radiation therapy (RT) in localized primary orbital mucosa-associated lymphoma tissue (MALT) lymphoma (POML)...
  19. doi request reprint Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience
    Jeremy F Sturgeon
    Department of Medical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    Eur Urol 59:556-62. 2011
    ..Since 1981 Princess Margaret Hospital has used initial active surveillance (AS) with delayed treatment at relapse as the preferred management for all patients with clinical stage I nonseminomatous germ cell tumors (NSGCT)...
  20. ncbi request reprint Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome
    Richard W Tsang
    Department of Radiation Oncology and Biostatistics, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    J Clin Oncol 21:4157-64. 2003
    ..We report the clinical outcome of stage I and II MALT lymphoma treated with involved field radiation therapy (RT)...
  21. ncbi request reprint Spermatocytic seminoma: a review
    Peter W M Chung
    Department of Radiation Oncology, Princess Margaret Hospital, 610, University of Toronto, Toronto, Ontario, Canada M5G 2M9
    Eur Urol 45:495-8. 2004
    ..Spermatocytic seminoma is a rare testicular tumour that has an extremely low rate of metastasis. We present a review of the management of this malignancy at our institution...
  22. ncbi request reprint Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma
    Jarad M Martin
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 69:1084-9. 2007
    ..To assess in a prospective trial the feasibility and late toxicity of hypofractionated radiotherapy (RT) for prostate cancer...
  23. doi request reprint PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer
    Andrew J McPartlin
    Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    Cancer 122:2595-603. 2016
    ..The authors report the long-term outcome of a phase 3 study of DE-EBRT with or without HT for patients with localized prostate cancer (LPC)...
  24. ncbi request reprint A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy
    Alan Nichol
    Radiation Medicine Program, Princess Margaret Hospital and University of Toronto, Toronto, Canada
    Radiother Oncol 76:11-7. 2005
    ..To prospectively evaluate toxicity, biochemical failure-free survival (bFFS) and biopsy-proven local control for prostate cancer patients treated with 75.6 Gy in 42 fractions using 6-field conformal radiotherapy to prostate alone...
  25. doi request reprint Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults
    Shane A Gangatharan
    Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
    Br J Haematol 170:384-90. 2015
    ..We conclude that YA with FL have a favourable prognosis compared to older patients; whether this reflects competing mortality risks or age-related differences in lymphoma biology warrants further investigation...
  26. ncbi request reprint Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response
    Michael Milosevic
    Radiation Medicine Program, Department of Medical Imaging, Princess Margaret Hospital, Toronto, Ontario, Canada
    Cancer Res 67:6022-5. 2007
    ....
  27. ncbi request reprint Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy
    Kirsty L Wiltshire
    Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 69:1090-9. 2007
    ..We sought to derive and validate an interdisciplinary consensus definition for the anatomic boundaries of the postoperative clinical target volume (CTV, prostate bed)...
  28. doi request reprint Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer
    Andrew Bayley
    Radiation Medicine Program, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 77:477-83. 2010
    ..To report the feasibility and early toxicity of dose-escalated image-guided IMRT to the pelvic lymph nodes (LN), prostate (P), and seminal vesicles (SV)...
  29. ncbi request reprint Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performance
    Daniel Letourneau
    Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 67:1229-37. 2007
    ..The technical challenges of this approach include cone-beam CT (CBCT) image quality for target definition, online planning, and efficient process integration...
  30. pmc Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate
    Douglas J Moseley
    Radiation Medicine Program, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 67:942-53. 2007
    ....
  31. ncbi request reprint Radiotherapy for bladder cancer
    Michael Milosevic
    Radiation Medicine Program, Princess Margaret Hospital, and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
    Urology 69:80-92. 2007
    ....
  32. ncbi request reprint Correction: Image guided dose escalated prostate radiotherapy: still room to improve
    Jarad M Martin
    Princess Margaret Hospital, Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Radiat Oncol 4:65. 2009
    ..The correct description of table 6 is: Univariate analysis of prognostic factors for 5-year nadir + 2 biochemical outcome for men presenting with intermediate risk factors...
  33. ncbi request reprint Semiautomatic vertebrae visualization, detection, and identification for online palliative radiotherapy of bone metastases of the spine
    Daniel Letourneau
    Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario M5G 2M9, Canada
    Med Phys 35:367-76. 2008
    ..The next step will be the clinical implementation of the algorithm within the online planning and delivery treatment technique for patients with spinal bone metastases...
  34. ncbi request reprint Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis
    Padraig Warde
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    J Clin Oncol 20:4448-52. 2002
    ..We performed a pooled analysis of patients from the four largest surveillance studies to better delineate prognostic factors associated with disease progression...
  35. ncbi request reprint Adjuvant carboplatin in stage I seminoma
    Padraig Warde
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, M5G 2M9, Canada
    Lancet 366:267-8. 2005
  36. ncbi request reprint Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and management
    Charles Catton
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Urol Clin North Am 30:751-63. 2003
    ....
  37. pmc Patient accessible electronic health records: exploring recommendations for successful implementation strategies
    David Wiljer
    University Health Network, 610 University Avenue, 5 973, Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada
    J Med Internet Res 10:e34. 2008
    ..Although many benefits have been identified, there are many questions about best practices for the implementation of patient accessible Electronic Health Records (EHRs)...
  38. ncbi request reprint Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
    Himu Lukka
    Radiation Oncology Program, Juravinski Cancer Centre, McMaster University, 699 Concession St, Hamilton, Ontario, Canada, L8V 5C2
    J Clin Oncol 23:6132-8. 2005
    ..The optimal radiation dose fractionation schedule for localized prostate cancer is unclear. This study was designed to compare two dose fractionation schemes (a shorter 4-week radiation schedule v a longer 6.5-week schedule)...
  39. doi request reprint Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: Impact on normal tissue dose
    Anne Marie Charpentier
    Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada
    Pract Radiat Oncol 4:174-80. 2014
    ....
  40. ncbi request reprint Radiotherapy for t3 prostate cancer
    Andrew Bayley
    Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Curr Urol Rep 4:205-10. 2003
    ..The contemporary role of radiation therapy in clinical T3 prostate cancer in the context of other treatment options is reviewed in this article...
  41. ncbi request reprint The process for continuous improvement of the TNM classification
    Mary K Gospodarowicz
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Cancer 100:1-5. 2004
    ..Furthermore, increased involvement by the experts should improve the understanding and dissemination of the TNM classification...
  42. ncbi request reprint Appropriate radiation volume for stage IIA/B testicular seminoma
    Peter W M Chung
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 56:746-8. 2003
    ..To address this issue, we reviewed patterns of failure and treatment outcome in patients treated with radiation therapy at our institution...
  43. doi request reprint Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy
    Jayant S Goda
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Cancer 116:3815-24. 2010
    ..This study was conducted to evaluate the long-term outcomes in patients with stage IE and IIE mucosa-associated lymphoid tissue (MALT) lymphomas treated with involved field radiotherapy (RT)...
  44. ncbi request reprint Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists
    Derek R Wilke
    Department of Radiation Oncology, Nova Scotia Cancer Centre, Capital Health, Halifax, Nova Scotia, Canada
    BJU Int 97:963-8. 2006
    ..To study the recovery of testosterone levels and erectile function in men who received radiotherapy plus long-term adjuvant androgen deprivation (LTAD) with luteinizing hormone-releasing hormone (LHRH) agonists...
  45. ncbi request reprint Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer
    Chris Parker
    Department of Biostatistics, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 58:750-7. 2004
    ..To describe the oxygenation of clinically localized prostate cancer...
  46. ncbi request reprint A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma
    Justin Lee
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Cancer 104:1894-900. 2005
    ..The authors conducted a prospective study to assess the effect of RT on symptoms and quality of life (QOL) in patients with metastatic RCC...
  47. ncbi request reprint Staging and management of localized non-Hodgkin's lymphomas: variations among experts in radiation oncology
    Richard W Tsang
    Department of Radiation Oncology, Princess Margaret Hospital Ontario Cancer Institute, University Health Network, University of Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 52:643-51. 2002
    ..Our aim was to identify the patterns of practice and areas of controversy that may need to be resolved and be amenable to prospective clinical trials...
  48. doi request reprint A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion
    Alan M Nichol
    Radiation Medicine Program, Princess Margaret Hospital and University of Toronto, Toronto, Canada
    Int J Radiat Oncol Biol Phys 77:1072-8. 2010
    ..To determine the reduction of prostate motion during a typical radiotherapy (RT) fraction from a bowel regimen comprising an antiflatulent diet and daily milk of magnesia...
  49. ncbi request reprint Clinical and biochemical outcome of conventional dose radiotherapy for localized prostate cancer
    Charles Catton
    Dept of Radiation Oncology, The Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Can J Urol 9:1444-52; discussion 1453. 2002
    ..To retrospectively review the results of conventional dose radical radiotherapy for clinical stage T1 and T2 prostate cancer, and to identify the factors that predict the biochemical relapse-free rate...
  50. ncbi request reprint Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1428-37. 2005
    ..We estimated this future risk, taking into account age and calendar year of HL diagnosis, HL treatment information, population breast cancer incidence rates, and competing causes of death...
  51. ncbi request reprint Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
    Flora E van Leeuwen
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Natl Cancer Inst 95:971-80. 2003
    ..Female survivors of Hodgkin's disease (HD) have a strongly elevated risk of breast cancer, but factors responsible for the increased risk are not well known...
  52. ncbi request reprint Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1354-65. 2005
    ..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors...
  53. ncbi request reprint Re: Vikram, B., The PSA conundrum. [Radiother Oncol, 2004. 71(1): p. 1-2]
    Kirsty Wiltshire
    Radiother Oncol 73:252-4; author reply 254-5. 2004
  54. ncbi request reprint Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    J Natl Cancer Inst 94:182-92. 2002
    ..We quantified the risk of treatment-associated lung cancer, taking into account tobacco use...
  55. ncbi request reprint Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence?
    Mary Gospodarowicz
    J Clin Oncol 20:3048-50. 2002
  56. pmc Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 106:3358-65. 2005
    ..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women...
  57. ncbi request reprint Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years
    Graca M Dores
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South, Suite 7039, Bethesda, MD 20892, USA
    J Clin Oncol 20:3484-94. 2002
    ....
  58. ncbi request reprint Noncancer causes of death in survivors of testicular cancer
    Sophie D Fossa
    Department of Clinical Cancer Research, Rikshospitalet Radiumhospitalet Trust, Oslo, Norway
    J Natl Cancer Inst 99:533-44. 2007
    ..We conducted a population-based study to quantify the long-term risks of mortality from noncancer causes among men with testicular cancer...
  59. ncbi request reprint Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma
    Lauren E Abrey
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 23:5034-43. 2005
    ..We hope that these guidelines will improve communication among investigators and comparability among clinical trials in a way that will allow us to develop better therapies for patients...
  60. ncbi request reprint Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    JAMA 290:465-75. 2003
    ..Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk...